Skip to main content

ASSURANT INC

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

AIZ$322.16+1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Consolidated Balance Sheets (unaudited)

September 30, 2024December 31, 2023
(in millions, except number of shares and per share amounts)
Assets
Investments:
Fixed maturity securities available for sale, at fair value (amortized cost - $7,766.4 and $7,292.4 at September 30, 2024 and December 31, 2023, respectively)$7,596.1$6,912.1
Equity securities at fair value219.4223.0
Commercial mortgage loans on real estate, at amortized cost (net of allowances for credit losses of $6.4 and $4.0 at September 30, 2024 and December 31, 2023, respectively)329.0328.7
Short-term investments325.0258.1
Other investments501.7499.0
Total investments8,971.28,220.9
Cash and cash equivalents1,813.41,627.4
Premiums and accounts receivable (net of allowances for credit losses of $6.3 and $9.0 at September 30, 2024 and December 31, 2023, respectively)1,782.62,265.6
Reinsurance recoverables (net of allowances for credit losses of $4.6 and $4.8 at September 30, 2024 and December 31, 2023, respectively)7,631.86,649.2
Accrued investment income120.397.0
Deferred acquisition costs10,083.89,967.2
Property and equipment, net742.2685.8
Goodwill2,625.22,608.8
Value of business acquired11.783.9
Other intangible assets, net545.9567.1
Other assets (net of allowances for credit losses of $0.7 at September 30, 2024 and December 31, 2023)1,004.2862.3
Total assets$35,332.3$33,635.2
Liabilities
Future policy benefits and expenses$504.0$487.2
Unearned premiums20,400.020,110.4
Claims and benefits payable3,049.01,989.2
Commissions payable526.2542.8
Reinsurance balances payable511.8430.1
Funds held under reinsurance257.8392.7
Accounts payable and other liabilities (including allowances for credit losses of $3.9 and $8.3 at September 30, 2024 and December 31, 2023, respectively, for the unsecured portion of the high deductible recoverables)2,745.72,792.7
Debt2,082.52,080.6
Total liabilities30,077.028,825.7
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock, par value $0.01 per share, 800,000,000 shares authorized, 53,672,292 and 54,252,083 shares issued and 51,376,203 and 51,955,994 shares outstanding at September 30, 2024 and December 31, 2023, respectively0.50.6
Additional paid-in capital1,683.31,668.5
Retained earnings4,321.54,028.2
Accumulated other comprehensive loss(627.2)(765.0)
Treasury stock, at cost; 2,296,089 shares at September 30, 2024 and December 31, 2023(122.8)(122.8)
Total equity5,255.34,809.5
Total liabilities and equity$35,332.3$33,635.2

Consolidated Statements of Operations (unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in millions, except number of shares and per share amounts)
Revenues
Net earned premiums$2,417.2$2,357.3$7,238.3$6,965.8
Fees and other income439.1310.41,200.0888.8
Net investment income129.7125.5381.1343.6
Net realized losses on investments (including $9.4, $0.8, $21.2 and $6.4 of impairment-related losses for the three and nine months ended September 30, 2024 and 2023, respectively) and fair value changes to equity securities(18.3)(19.1)(46.7)(49.7)
Total revenues2,967.72,774.18,772.78,148.5
Benefits, losses and expenses
Policyholder benefits776.8644.62,096.01,922.7
Underwriting, selling, general and administrative expenses2,012.71,873.75,919.25,564.5
Interest expense26.727.080.281.2
Gain on extinguishment of debt———(0.1)
Total benefits, losses and expenses2,816.22,545.38,095.47,568.3
Income before income tax expense151.5228.8677.3580.2
Income tax expense17.738.7118.4120.2
Net income$133.8$190.1$558.9$460.0
Earnings Per Common Share
Basic$2.56$3.55$10.66$8.58
Diluted$2.55$3.54$10.60$8.55
Share Data
Weighted average common shares outstanding used in basic per common share calculations52,204,05753,535,98252,411,45753,591,495
Plus: Dilutive securities260,465209,191293,417232,889
Weighted average common shares outstanding used in diluted per common share calculations52,464,52253,745,17352,704,87453,824,384

Consolidated Statements of Comprehensive Income (unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in millions)
Net income$133.8$190.1$558.9$460.0
Other comprehensive income (loss):
Change in unrealized losses on securities, net of taxes of $(56.2), $30.2, $(42.4) and $19.1 for the three and nine months ended September 30, 2024 and 2023, respectively209.7(112.9)154.5(80.6)
Change in unrealized gains on derivative transactions, net of taxes of $(0.8), $0.3, $0.3 and $(0.3) for the three and nine months ended September 30, 2024 and 2023, respectively3.0(1.2)(1.1)1.0
Change in foreign currency translation, net of taxes of $2.8, $0.4, $4.6 and $(1.7) for the three and nine months ended September 30, 2024 and 2023, respectively15.2(11.3)(8.4)22.4
Change in pension and postretirement unrecognized net periodic benefit cost, net of taxes of $0.7, $0.7, $2.0 and $2.0 for the three and nine months ended September 30, 2024 and 2023, respectively(2.4)(2.9)(7.2)(7.6)
Total other comprehensive income (loss)225.5(128.3)137.8(64.8)
Total comprehensive income$359.3$61.8$696.7$395.2

Consolidated Statements of Changes in Equity (unaudited)

Three Months Ended September 30, 2024
Common StockAdditionalPaid-inCapitalRetainedEarningsAccumulatedOtherComprehensiveLossTreasuryStockTotal
(in millions)
Balance at June 30, 2024$0.5$1,669.6$4,309.7$(852.7)$(122.8)$5,004.3
Stock plan exercises—7.5———7.5
Stock plan compensation expense—23.7———23.7
Common stock dividends ($0.72 per share)——(37.5)——(37.5)
Acquisition of common stock—(17.5)(84.5)——(102.0)
Net income——133.8——133.8
Other comprehensive income———225.5—225.5
Balance at September 30, 2024$0.5$1,683.3$4,321.5$(627.2)$(122.8)$5,255.3
Three Months Ended September 30, 2023
Common StockAdditionalPaid-inCapitalRetainedEarningsAccumulatedOtherComprehensive LossTreasuryStockTotal
(in millions)
Balance at June 30, 2023$0.6$1,653.7$3,877.2$(922.7)$(122.8)$4,486.0
Stock plan exercises—7.5———7.5
Stock plan compensation expense—23.9———23.9
Common stock dividends ($0.70 per share)——(37.1)——(37.1)
Acquisition of common stock—(12.0)(39.5)——(51.5)
Net income——190.1——190.1
Other comprehensive loss———(128.3)—(128.3)
Balance at September 30, 2023$0.6$1,673.1$3,990.7$(1,051.0)$(122.8)$4,490.6
Nine Months Ended September 30, 2024
Common StockAdditionalPaid-inCapitalRetainedEarningsAccumulatedOtherComprehensive LossTreasuryStockTotal
(in millions)
Balance at December 31, 2023$0.6$1,668.5$4,028.2$(765.0)$(122.8)$4,809.5
Stock plan exercises—14.8———14.8
Stock plan compensation expense—58.3———58.3
Common stock dividends ($2.16 per share)——(114.8)——(114.8)
Acquisition of common stock(0.1)(58.3)(150.8)——(209.2)
Net income——558.9——558.9
Other comprehensive income———137.8—137.8
Balance at September 30, 2024$0.5$1,683.3$4,321.5$(627.2)$(122.8)$5,255.3

Consolidated Statements of Changes in Equity (unaudited)

Nine Months Ended September 30, 2023
Common StockAdditionalPaid-inCapitalRetainedEarningsAccumulatedOtherComprehensiveLossTreasuryStockTotal
(in millions)
Balance at December 31, 2022$0.6$1,637.8$3,699.3$(986.2)$(122.8)$4,228.7
Stock plan exercises—14.9———14.9
Stock plan compensation expense—53.6———53.6
Common stock dividends ($2.10 per share)——(113.8)——(113.8)
Acquisition of common stock—(33.2)(54.8)——(88.0)
Net income——460.0——460.0
Other comprehensive loss———(64.8)—(64.8)
Balance at September 30, 2023$0.6$1,673.1$3,990.7$(1,051.0)$(122.8)$4,490.6

Consolidated Statements of Cash Flows (unaudited)

Nine Months Ended September 30,
20242023
(in millions)
Operating activities
Net income$558.9$460.0
Adjustments to reconcile net income to net cash provided by operating activities:
Noncash revenues, expenses, gains and losses included in net income from operations:
Deferred tax expense (benefit)219.9(69.1)
Depreciation and amortization159.6141.2
Net realized losses on investments, including impairment losses46.749.7
Gain on extinguishment of debt—(0.1)
Stock based compensation expense58.353.6
Restructuring costs0.218.3
Changes in operating assets and liabilities:
Insurance policy reserves and expenses1,409.866.9
Premiums and accounts receivable485.710.4
Commissions payable(8.7)(39.3)
Reinsurance recoverable(968.2)330.8
Reinsurance balance payable83.5(77.0)
Funds withheld under reinsurance(134.3)36.4
Deferred acquisition costs and value of business acquired(75.0)(68.4)
Taxes receivable(167.3)(45.4)
Other assets and other liabilities(387.6)(83.8)
Other(51.6)(8.7)
Net cash provided by operating activities1,229.9775.5
Investing activities
Sales of:
Fixed maturity securities available for sale924.6955.7
Equity securities73.811.1
Other invested assets71.030.0
Maturities, calls, prepayments, and scheduled redemption of:
Fixed maturity securities available for sale384.2199.2
Commercial mortgage loans on real estate35.415.4
Purchases of:
Fixed maturity securities available for sale(1,822.9)(1,495.6)
Equity securities(55.4)(3.4)
Commercial mortgage loans on real estate(38.1)(44.4)
Other invested assets(66.8)(37.0)
Property and equipment and other(153.3)(148.2)
Subsidiaries, net of cash transferred(12.9)(0.3)
Change in short-term investments(68.4)(124.0)
Other—0.7
Net cash used in investing activities(728.8)(640.8)
Financing activities
Issuance of debt, net of issuance costs—173.2
Repayment of debt—(225.0)

Consolidated Statements of Cash Flows (unaudited)

Nine Months Ended September 30,
20242023
Payment of contingent liability—(2.5)
Acquisition of common stock(187.1)(67.1)
Common stock dividends paid(114.8)(113.8)
Employee stock purchases and withholdings(15.9)(6.7)
Net cash used in financing activities(317.8)(241.9)
Effect of exchange rate changes on cash and cash equivalents2.7(4.2)
Change in cash and cash equivalents186.0(111.4)
Cash and cash equivalents at beginning of period1,627.41,536.7
Cash and cash equivalents at end of period$1,813.4$1,425.3

INDEX OF NOTES

NotePage Number
1. Nature of Operations9
2. Basis of Presentation9
3. Recent Accounting Pronouncements10
4. Segment Information12
5. Contract Revenues14
6. Investments15
7. Fair Value Disclosures19
8. Deferred Acquisition Costs22
9. Reserves23
10. Accumulated Other Comprehensive Income26
11. Earnings Per Common Share28
12. Retirement and Other Employee Benefits29
13. Restructuring and Related Impairment Charges30
14. Commitments and Contingencies31
15. Subsequent Event31
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.